121 related articles for article (PubMed ID: 18588863)
1. Characterization of asymmetric fluorogenic phosphonates as probes for developing organophosphorus hydrolases with broader stereoselectivity.
Amitai G; Adani R; Limanovich O; Teitlboim S; Yishay S; Tveria L; Yacov G; Meshulam H; Raveh L
Chem Biol Interact; 2008 Sep; 175(1-3):249-54. PubMed ID: 18588863
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
5. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
6. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
7. A fluorogenic substrate for detection of organophosphatase activity.
Soukharev S; Hammond DJ
Anal Biochem; 2004 Apr; 327(1):140-8. PubMed ID: 15033522
[TBL] [Abstract][Full Text] [Related]
8. Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.
Ashani Y; Gupta RD; Goldsmith M; Silman I; Sussman JL; Tawfik DS; Leader H
Chem Biol Interact; 2010 Sep; 187(1-3):362-9. PubMed ID: 20303930
[TBL] [Abstract][Full Text] [Related]
9. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
10. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
[TBL] [Abstract][Full Text] [Related]
12. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
13. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
14. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.
Costa LG; Cole TB; Vitalone A; Furlong CE
Clin Chim Acta; 2005 Feb; 352(1-2):37-47. PubMed ID: 15653099
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
Jokanović M
Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
[TBL] [Abstract][Full Text] [Related]
16. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes.
Oh KA; Park NJ; Park NS; Kuca K; Jun D; Jung YS
Chem Biol Interact; 2008 Sep; 175(1-3):365-7. PubMed ID: 18565503
[TBL] [Abstract][Full Text] [Related]
18. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
[TBL] [Abstract][Full Text] [Related]
19. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
Rochu D; Chabrière E; Masson P
Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
[TBL] [Abstract][Full Text] [Related]
20. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
